209 related articles for article (PubMed ID: 31027143)
1. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma.
Liu X; Meng J; Xu H; Niu J
Medicine (Baltimore); 2019 Apr; 98(17):e15414. PubMed ID: 31027143
[TBL] [Abstract][Full Text] [Related]
2. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Wang G; Lu X; Du Q; Zhang G; Wang D; Wang Q; Guo X
Sci Rep; 2020 Aug; 10(1):13519. PubMed ID: 32782270
[TBL] [Abstract][Full Text] [Related]
5. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
[TBL] [Abstract][Full Text] [Related]
6. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
[No Abstract] [Full Text] [Related]
7. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
8. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Li J; Tao H; Zhang E; Huang Z
Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
[TBL] [Abstract][Full Text] [Related]
10. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis.
Li S; Liu D; Wang Q
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649525
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
[TBL] [Abstract][Full Text] [Related]
12. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
[No Abstract] [Full Text] [Related]
14. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X
BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306
[TBL] [Abstract][Full Text] [Related]
15. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China.
Chi X; Jiang L; Yuan Y; Huang X; Yang X; Hochwald S; Liu J; Huang H
BMC Gastroenterol; 2022 Apr; 22(1):202. PubMed ID: 35461226
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.
Wen CP; Lin J; Yang YC; Tsai MK; Tsao CK; Etzel C; Huang M; Hsu CY; Ye Y; Mishra L; Hawk E; Wu X
J Natl Cancer Inst; 2012 Oct; 104(20):1599-611. PubMed ID: 23073549
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
19. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]